Synarel Spray, Metered
Product Images NDC 0025-0166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Synarel (NDC 0025-0166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Synarel 01)

FDA Label Image

Logo (Synarel 02)

Logo (Synarel 02)
This is a label of a medication named Pfizer, distributed by Pfizer Labs, a division of Pfizer Inc. The medication is made in New York, NY 10017.*
FDA Label Image

Chemical Structure (Synarel 03)

FDA Label Image

Figure (Synarel 04)

Figure (Synarel 04)
This is a list of adverse events reported during a 6-month treatment with Synarel® 400 pg/day versus Danazol 600 or 800 mg/day. The adverse events are categorized into hypostrogenic, androgenic, local, and miscellaneous. Hypostrogenic adverse events include hot flashes, decreased libido, vaginal dryness, and insomnia. Androgenic adverse events include breast size reduction, edema, seborrhea, weight gain, hirsutism, and increased libido. Local adverse events include nasal irritation, while miscellaneous adverse events include depression and weight loss. There is also a graph showing the percentage of patients experiencing these adverse events.*
FDA Label Image

Logo (Synarel 05)

Logo (Synarel 05)
This is a label for a product distributed by Pfizer Labs, a division of Pfizer Inc. The location of the company is in New York, NY 10017.*
FDA Label Image

Figure A (Synarel 06)

FDA Label Image

Figure B (Synarel 07)

FDA Label Image

Figure C (Synarel 08)

FDA Label Image

Figure D (Synarel 09)

FDA Label Image

Figure E (Synarel 10)

FDA Label Image

Figure F (Synarel 11)

FDA Label Image

Figure G (Synarel 12)

FDA Label Image

Figure H (Synarel 13)

FDA Label Image

Figure I (Synarel 14)

FDA Label Image

Figure J (Synarel 15)

FDA Label Image

Logo (Synarel 16)

FDA Label Image

Figure A (Synarel 17)

FDA Label Image

Figure B (Synarel 18)

FDA Label Image

Figure C (Synarel 19)

FDA Label Image

Figure D (Synarel 20)

FDA Label Image

Figure E (Synarel 21)

FDA Label Image

Figure F (Synarel 22)

FDA Label Image

Figure G (Synarel 23)

FDA Label Image

Figure H (Synarel 24)

FDA Label Image

Figure I (Synarel 25)

FDA Label Image

Figure J (Synarel 26)

FDA Label Image

Figure K (Synarel 27)

FDA Label Image

Logo (Synarel 28)

Logo (Synarel 28)
This is a label with information about a medication called Pfizer. It is distributed by the Pfizer Labs division of Pfizer Inc. and is located in New York City with a zip code of 10017.*
FDA Label Image

Principal Display Panel (8 mL Bottle Label)

FDA Label Image

Principal Display Panel (8 mL Bottle Carton)

Principal Display Panel (8 mL Bottle Carton)
Synarel® (nafarelin acetate) nasal solution is a medication delivered intranasally with each actuation delivering approximately 200 meg nafarelin. The carton comes with a bottle of nasal solution along with spray pump, patient information, and complete prescribing information. It contains 2 mg/mL nafarelin base in benzalkonium chloride, glacial acetic acid, sodium hydroxide or hydrochloric acid (to adjust pH), sorbitol, and purified water. This medication should be stored upright at a temperature range of 15-30°C and kept away from light and children. Dosage and use details are provided in the accompanying prescribing information. This product is distributed by Pfizer Labs Division of Pfizer Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.